Study to Evaluate Safety and Tolerability of sc Immunotherapy With DM-101 in Adults With Birch Pollen Allergy

NCT04266028 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Birch Pollen Allergy

Interventions

BIOLOGICAL: DM-101
BIOLOGICAL: Placebo to match DM-101

Sponsor

Desentum Oy